□适用 √不适用 二、经营情况的讨论与分析 围绕年初制定的"坚定不移推进全面深化改革提升集团核心竞争力，奋力推动新型工业化和制造业高质 量发展迈出新步伐"的目标，稳中求进，守正创新，克服种种困难，扎实推进各项年度重点工作，基本 完成时间过半、任务过半，取得了来之不易的成绩，为完成全年目标任务夯实基础。 安全环保总体受控，严格落实"三管三必须"工作要求，不断夯实全员安全生产责任制；对照方案、 踏准节点，有序推进治本攻坚三年行动；强化安全监督，筑牢风险防控屏障，每季度开展覆盖所有二级 公司、重点三级工厂的安全生产大检查；推进承包商"同质化"管理，试点开展承包商安全标准化管理 单位:元 币种:人民币 非经常性损益项目 金额 附注（如适用） 非流动性资产处置损益，包括已计提资产减值准备的冲销部分 17,671,515.23 计入当期损益的政府补助，但与公司正常经营业务密切相关、符 合国家政策规定、按照确定的标准享有、对公司损益产生持续影 61,697,896.56 响的政府补助除外 上海华谊集团股份有限公司2025 年半年度报告 除同公司正常经营业务相关的有效套期保值业务外，非金融企业 持有金融资产和金融负债产生的公 ...

资金流向方面，卫星化学8月22日主力资金净流出1.2亿元，近五个交易日累计净流出4.83亿元。在所属 的基础化工行业中，当日全行业主力资金净流出20.95亿元。 风险提示：以上内容仅供参考，不构成投资建议。市场有风险，投资需谨慎。 截至2025年8月22日15时，卫星化学股价报19.89元，较前一交易日下跌0.45%。当日成交量为58.2万 手，成交金额达11.57亿元，振幅为1.85%。公司当前总市值670.02亿元，市盈率12.21倍。 卫星化学属于基础化工行业，主营业务涵盖丙烯酸及酯、高分子乳液等化工产品的研发、生产和销售。 公司产品广泛应用于建筑、纺织、包装等领域。 公开信息显示，社保基金在今年二季度新进成为卫星化学前十大流通股东，持仓市值达3.5亿元。与此 同时，公募基金也对该股进行了配置，显示出机构投资者对公司的一定关注。 ...

Group 1 - The stock price of Satellite Chemical is reported at 18.86 yuan, down 0.04 yuan or 0.21% from the previous trading day, with a trading volume of 872 million yuan and a turnover rate of 1.37% [1] - Satellite Chemical operates in the chemical raw materials sector, focusing on the research, production, and sales of products such as acrylic acid and esters, and high polymer emulsions [1] - The company is advancing its industrial chain towards high-end new materials through a light hydrocarbon raw material route [1] Group 2 - Zhongyin Securities has issued a report giving Satellite Chemical a "buy" rating, highlighting the resilience of its light hydrocarbon route and significant growth in functional chemical products, with expectations for its high-end new materials layout to drive industrial upgrades [1] - In the second quarter, pension accounts newly held 1,996,720 shares of Satellite Chemical, ranking it among the top holdings in pension funds [1] - The company has also introduced a "liquid cooling concept" due to its research and development in immersion liquid cooling fluids [1] Group 3 - On August 19, the main funds saw a net inflow of 30.57 million yuan into Satellite Chemical, accounting for 0.05% of its circulating market value; however, over the past five days, there has been a cumulative net outflow of 371 million yuan, representing 0.58% of its circulating market value [1]

Core Viewpoint - Satellite Chemical (002648) is positioned for growth with functional chemicals as the main driver, supported by continuous R&D investment [1][2] Financial Performance - In H1 2025, the company achieved total revenue of 23.46 billion yuan, a year-on-year increase of 20.9%, and a net profit attributable to shareholders of 2.74 billion yuan, up 33.4% year-on-year [1] - In Q2 2025, total revenue was 11.13 billion yuan, with quarter-on-quarter changes of +5.1% and -9.7%, while net profit was 1.18 billion yuan, with quarter-on-quarter changes of +13.7% and -25.1% [1] Segment Performance - In H1 2025, revenue from functional chemicals, polymer materials, and new energy materials was 12.22 billion, 5.25 billion, and 300 million yuan, respectively, with year-on-year growth rates of +32.1%, -4.4%, and -14.8% [2] - Gross margins for these segments were 19.92%, 29.54%, and 21.63%, showing improvements of 2.64 percentage points, 0.74 percentage points, and 0.30 percentage points year-on-year [2] - Overall sales gross margin and net margin for H1 2025 were 20.56% and 11.69%, with year-on-year changes of -0.52 percentage points and +1.11 percentage points [2] Strategic Initiatives - The company is enhancing its supply chain integration, having completed its downstream chemical layout in the C2 sector, with capacities including 1.82 million tons of ethylene glycol and 500,000 tons of polyether monomers [2] - In the C3 sector, it has established the largest acrylic acid and ester production capacity in China and the second largest globally, with a new project in 2024 expected to produce 800,000 tons of multi-carbon alcohols [2] R&D Investment - The company plans to invest 10 billion yuan in R&D, focusing on key strategic materials and advanced new materials, with its R&D center set to begin construction in May 2024 [3] - During the reporting period, the company filed 122 patents and received 57 authorized patents, with R&D expenses amounting to 773 million yuan [3] - In the green data center sector, the company is developing hydrocarbon-based immersion cooling liquids, which have potential as a mainstream cooling technology due to their energy-saving and environmentally friendly properties [3] Investment Recommendations - The company is projected to achieve net profits of 6.36 billion, 7.60 billion, and 9.63 billion yuan for 2025, 2026, and 2027, respectively, with corresponding price-to-earnings ratios of 10, 8, and 7 times based on the closing price of 18.85 yuan on August 13 [4]

资金方面，卫星化学8月13日主力资金净流出2.12亿元，近五日累计净流出1.01亿元。 截至2025年8月13日15时，卫星化学股价报18.85元，较前一交易日下跌1.21%。当日成交额达10.40亿 元，振幅为1.78%。 卫星化学属于化学原料板块，主要从事丙烯酸及酯、高分子乳液等化工产品的研发、生产和销售。公司 是国内领先的C2、C3产业链一体化企业，产品广泛应用于建筑、纺织、包装等领域。 消息面上，国信证券发布研报称，卫星化学2025年上半年归母净利润同比增长33.4%，新材料项目有望 打开未来成长空间。此外，QFII二季度持仓数据显示，卫星化学获外资机构持有，持仓市值超过4亿 元。社保基金101组合也在二季度新进成为公司前十大流通股东。 风险提示：市场有风险，投资需谨慎。 ...

Core Viewpoint - The company aims to become a world-class chemical new materials technology company, focusing on high-quality development in the C2 and C3 industrial chains, with continuous innovation in functional chemicals, polymer new materials, new energy materials, hydrogen energy, and comprehensive utilization of carbon dioxide [1]. Financial Performance - The company reported a revenue of 23.46 billion yuan for the current reporting period, representing a year-on-year increase of 20.93% compared to 19.40 billion yuan in the same period last year [4]. - The net profit attributable to shareholders reached 2.74 billion yuan, up 33.44% from 2.06 billion yuan in the previous year [4]. - The net profit after deducting non-recurring gains and losses was 2.90 billion yuan, reflecting a 29.61% increase from 2.23 billion yuan [4]. - The net cash flow from operating activities was 5.05 billion yuan, a significant increase of 138.88% from 2.12 billion yuan [4]. - Basic and diluted earnings per share were both 0.81 yuan, marking a 32.79% increase from 0.61 yuan [4]. - The weighted average return on equity was 8.61%, up 0.80% from 7.81% [4]. C2 Sector Development - The company has established a comprehensive development matrix for downstream chemicals of ethylene oxide, with production capacities of 1.82 million tons of ethylene glycol, 500,000 tons of polyether monomers and surfactants, 200,000 tons of ethanolamine, and 150,000 tons of carbonates [2]. - The market share of ethanolamine and polyether monomers has steadily increased, with actual production ranking first and second nationally, respectively, both exceeding 20% market share [2]. - The company’s polyethylene and polystyrene products are tailored to market demands, with polyethylene recognized as an industry benchmark for stability and low impurity content, while polystyrene has improved toughness and high-temperature resistance, entering the core supply chain of major home appliance clients [2]. C3 Sector Development - The company has built the largest domestic and second-largest global production capacity for acrylic acid and esters [3]. - The new materials and new energy integrated project at the Pinghu base, with an annual production capacity of 800,000 tons of multi-carbon alcohol, successfully commenced operations, creating a closed-loop industrial chain with acrylic acid [3]. - The company has established the Satellite Global Company to accelerate overseas market expansion, with exports of acrylic acid and esters, polyether monomers, ethanolamine, and superabsorbent resins ranking among the top in China, collaborating with over 160 countries and regions [3].

Investment Rating - The report initiates coverage on Huayi Group with an "Accumulate" rating and sets a target price of RMB 9.72, based on a 2025 PE of 18x [1][6]. Core Views - Huayi Group is a comprehensive chemical enterprise controlled by the Shanghai State-owned Assets Supervision and Administration Commission, with business segments including coal-based methanol/acetic acid, acrylic acid, tires, coatings, daily chemicals, and chemical services. The company's methanol/acetic acid/acrylic acid business is expected to benefit from price elasticity due to its scale advantages. With the ongoing state-owned enterprise reform, the continuous injection of quality assets from the controlling shareholder, such as San Aifu and Guangxi Energy Chemical, is likely to lead to a revaluation of the company's value [1][14]. Summary by Sections Company Overview - Huayi Group is a large chemical group controlled by the Shanghai State-owned Assets Supervision and Administration Commission, with a diversified business portfolio that includes coal-based methanol/acetic acid, acrylic acid, tires, coatings, daily chemicals, and chemical services. The company has a significant market presence in methanol and acetic acid production [19][22]. Production Capacity - The company has leading production capacities in methanol (1.61 million tons/year), acetic acid (1.3 million tons/year), and acrylic acid (720,000 tons/year), positioning it among the top in the industry. The expansion of MTO (Methanol to Olefins) and the impact of geopolitical conflicts on imported methanol supply may lead to a tight supply situation for methanol, while acetic acid and acrylic acid are expected to stabilize and recover in profitability [2][15]. Business Synergy and Asset Injection - The company has been enhancing its business synergy through the acquisition of quality assets from its controlling shareholder. The acquisition of a 60% stake in Shanghai Huayi San Aifu New Materials for RMB 4.09 billion has strengthened its position in the fluorochemical sector. The integration of various business segments is expected to improve operational efficiency and profitability [16][17]. Market Revaluation Potential - The company is currently trading below its book value (PB < 1), and with the ongoing state-owned enterprise reforms and the expected improvement in performance, there is potential for a revaluation of the company's market value. The continuous injection of quality assets from the controlling shareholder is anticipated to enhance the company's overall value [4][17][18]. Financial Projections - The report forecasts the company's net profit attributable to shareholders to be RMB 1.14 billion, RMB 1.38 billion, and RMB 1.56 billion for the years 2025, 2026, and 2027, respectively, representing year-on-year growth rates of 25%, 21%, and 13%. The corresponding EPS is projected to be RMB 0.54, RMB 0.65, and RMB 0.73 for the same years [6][11].

Group 1 - The 12th World Congress of Chemical Engineering and the 21st Asia-Pacific Chemical Alliance Conference opened, highlighting China's position as the largest producer and consumer in the global chemical industry [1] - In the fine chemical sector, China's revenue accounts for 50% of the global market share [1] Group 2 - Comprehensive leading companies include Wanhua Chemical, the largest global MDI producer, and New Chemical Materials, which covers the entire industrial chain of polyurethane, petrochemicals, new materials, and fine chemicals [4] - Other leading companies in specific segments include Longbai Group, the world's largest titanium dioxide producer, and Yuntianhua, a domestic leader in phosphate resources [4][5] Group 3 - Potential companies include Yuanli Technology, which has the world's largest production capacity for dimethyl adipate, and Zhongyan Chemical, the global leader in sodium metal production [5]

Core Insights - The report highlights that the recent improvement in supply-demand policies is expected to partially reverse the current unfavorable economic situation, driven by increased domestic demand from projects like the Yaxia Hydropower Station and ongoing "anti-involution" policies [4][10] - The cyclical stocks have shown strong performance recently, with the market's expectations for price improvements rapidly increasing, indicating a potential continuation of market valuation support in the short term [4][10] - The report emphasizes that the current market environment is characterized by ample liquidity, which, combined with the low valuation levels of cyclical sectors, has contributed to the rapid upward movement of these stocks [4][10] Stock Recommendations - The August stock selection includes: SF Express (transportation), Satellite Chemical (chemicals), Anji Technology (chemicals), Heng Rui Medicine (pharmaceuticals), Bairen Medical (pharmaceuticals), Beijing Renli (services), Feiliwa (electronics), Industrial Fulian (electronics), Pengding Holdings (electronics), and Hehe Information (computers) [10][11] - The report notes that the July stock selection achieved an absolute return of 9.64%, outperforming the market benchmark (CSI 300) by 6.10 percentage points, with individual stocks like Jitu Express-W and Shenghong Technology yielding returns of 57.23% and 42.94%, respectively [6][10] Industry Analysis Transportation Sector - SF Express reported a steady growth in Q1 2025, with a net profit of 2.234 billion yuan, a year-on-year increase of 16.87%, driven by an improved product matrix and service competitiveness [12][13] Chemical Sector - Satellite Chemical achieved a record high net profit in Q4 2024, benefiting from stable raw material prices and increased sales margins, with a sales gross margin of 27.11% [14][15] - Anji Technology experienced rapid revenue growth in 2024, with a gross margin of 58.45%, attributed to market expansion and product diversification [17][18] Pharmaceutical Sector - Heng Rui Medicine's overseas licensing agreements have contributed to significant revenue growth, with Q4 2024 net profit increasing by 107.20% year-on-year [20][21] - Bairen Medical's revenue growth was driven by the successful launch of its first interventional valve product, which significantly boosted its performance in 2024 [22][23] Service Sector - Beijing Renli has a strong market presence in the human resources industry, with a broad service offering and a robust client base, positioning it for continued growth [25][26] Electronics Sector - Feiliwa is expanding its production capacity in quartz fiber cloth, targeting the growing demand in the PCB market, with a projected CAGR of 12% from 2024 to 2029 [27][28] - Industrial Fulian's cloud computing business has shown significant growth, with revenue from AI servers increasing by over 150% [31][32] - Pengding Holdings is expected to achieve steady revenue and profit growth in the first half of 2025, driven by cost control and product structure optimization [33][34]

Core Viewpoint - The current market is in a bull phase, with significant losses reported among short sellers in commodity and stock index futures. The article suggests that the most certain investment opportunities in a bull market are either in leading sectors or in severely undervalued stocks [2]. Group 1: Investment Opportunities - The article emphasizes that low-priced stocks tend to be driven up to reasonable levels during a bull market, indicating that underperforming sectors may see substantial gains due to ongoing liquidity and policy support [2]. - The upcoming major meetings are expected to enhance expectations for "stabilizing growth," which may provide considerable policy space for undervalued industries [2]. Group 2: ETF Analysis - The article utilizes the net value percentile calculation method to assess which sectors are currently in a state of severe undervaluation [3]. - A table is provided showing various ETFs, their net value percentiles since 2023 and 2024, and their performance in 2025, highlighting sectors like photovoltaic, alcohol, and real estate [7]. Group 3: Sector-Specific Insights - The photovoltaic sector is identified as particularly undervalued, with ETFs like the photovoltaic ETF (515790.SH) and new energy ETF (516160.SH) showing significant declines. The sector's performance is closely tied to government policies aimed at stabilizing growth [9][10]. - The alcohol sector, particularly the alcohol ETF (512690.SH), is also noted for being in a state of decline, with a lack of clear catalysts for recovery until consumer data improves [20][21]. - The real estate sector shows signs of divergence, with the real estate ETF (159707.SZ) experiencing intermittent policy-driven rallies but ultimately returning to lower levels [25][26]. Group 4: Medical and Pharmaceutical Sector - The medical and pharmaceutical sectors are highlighted as being collectively undervalued, with various ETFs like the biopharmaceutical ETF (159859.SZ) showing potential for recovery due to recent policy shifts regarding procurement practices [33][35]. - The medical ETF (512170.SH) is also mentioned as being in a relatively low valuation position, with a modest performance outlook [39]. Group 5: Commodity and Chemical Sectors - The coal sector has seen a significant price drop but is experiencing a rebound due to rising prices in coking coal and coke futures, with the coal ETF (515220.SH) reflecting this trend [43][45]. - The chemical sector is noted for its broad product range and recent price increases in lithium carbonate, with the chemical ETF (159870.SZ) positioned as relatively undervalued [49][54]. Conclusion - The article concludes that sectors such as chemicals, biopharmaceuticals, medical, alcohol, and photovoltaic are currently in a state of severe undervaluation, presenting potential investment opportunities for discerning investors [56].